LMP2-DC Vaccine Elicits Specific EBV-LMP2 Response to Effectively Improve Immunotherapy in Patients with Nasopharyngeal Cancer.
Zeng Y, Si YF, Lan GP, Wang Z, Zhou L, Tang MZ, Sj OB, Lan J, Zhou XY, Wang YL, Tang J, Zhou ZX, Du HJ, Lin H.
Zeng Y, et al. Among authors: zhou zx, zhou l, zhou xy.
Biomed Environ Sci. 2020 Nov 20;33(11):849-856. doi: 10.3967/bes2020.115.
Biomed Environ Sci. 2020.
PMID: 33771238
Free article.
Clinical Trial.